Artificial Intelligence (AI) at Doheny: Learn about AI as an emerging and exciting tool to aid in diagnosing ocular disease as well as its capabilities to link disease prevention, treatment and patient outcomes.
A conversation about clinical trials with Dr. Alfredo Sadun. Patients in treatment often ask about participation in these drug tests. Dr. Sadun explains how doctors and researchers decide who makes a good candidate for a clinical trial, how to ensure a trial is legitimate, and the impact of clinical trial research on his own work throughout his career in neuro-ophthalmology.
A conversation with Dr. Ali Khan about the newest therapies, and drug delivery options for patients with wet Age-related Macular Degeneration, and the best ways to get involved with stem cell trials.
Steven Barnes, PhD, shares how physicians will deliver earlier treatments for those with retinal disease.
Dr. Barnes shares how the cells in the retina are vital to show disease and its progression. His work to study these cells and the signals they provide will allow physicians to deliver earlier treatments for those with retinal disease.
David Garway-Heath, MD, FRCOphth, President of the European Glaucoma Society, and Alex Huang, MD, PhD discuss how advances in technology and collaboration continuously enhance patient care globally.
How one savvy patient partnered with a Doheny doctor to pursue cutting edge treatment to save her sight. A conversation with television producer Lauren Dascher, and Dr. Olivia Lee.